We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.36%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$23.6B
AUM Growth
-$1.2B
(-4.8%)
Cap. Flow
-$152M
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
59.63%
Holding
1,742
New
84
Increased
209
Reduced
452
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$117M |
| 2 |
Entegris
ENTG
|
+$107M |
| 3 |
Teleflex
TFX
|
+$26.6M |
| 4 |
Nike
NKE
|
+$25.8M |
| 5 |
S&P Global
SPGI
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.9M |
| 2 |
Meta Platforms (Facebook)
META
|
+$53.8M |
| 3 |
IAA
IAA, Inc. Common Stock
IAA
|
+$39.5M |
| 4 |
Amazon
AMZN
|
+$37.6M |
| 5 |
UnitedHealth
UNH
|
+$30M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.69% |
| 2 | Technology | 15.09% |
| 3 | Healthcare | 11.64% |
| 4 | Consumer Discretionary | 8.73% |
| 5 | Communication Services | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $571K | ﹤0.01% |
7,200
| – | – |
|
|
CMA
477
DELISTED
Comerica
CMA
| $570K | ﹤0.01% |
8,025
| – | – |
|
478
Target
TGT
$62.1B
| $560K | ﹤0.01% |
3,774
+150
| +4% | +$24K |
|
479
Omega Healthcare
OHI
$15.4B
| $552K | ﹤0.01% |
18,725
| – | – |
|
|
MDC
480
DELISTED
M.D.C. Holdings, Inc.
MDC
| $550K | ﹤0.01% |
20,060
-196
| -1% | -$6.49K |
|
481
Datadog
DDOG
$87.9B
| $549K | ﹤0.01% |
6,195
| – | – |
|
482
Schwab International Equity ETF
SCHF
$65.6B
| $549K | ﹤0.01% |
39,066
+1,532
| +4% | +$24K |
|
483
ServiceNow
NOW
$102B
| $548K | ﹤0.01% |
7,260
-1,250
| -15% | -$113K |
|
484
Corning
GLW
$126B
| $547K | ﹤0.01% |
18,861
+2,400
| +15% | +$81.3K |
|
485
Citizens Community Bancorp
CZWI
$227M
| $537K | ﹤0.01% |
44,174
| – | – |
|
486
Prologis
PLD
$138B
| $534K | ﹤0.01% |
5,263
-100
| -2% | -$12.4K |
|
487
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
| $530K | ﹤0.01% |
18,000
| – | – |
|
488
Webster Financial
WBS
$12.3B
| $528K | ﹤0.01% |
11,682
+3
| +0% | +$139 |
|
489
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
| $523K | ﹤0.01% |
6,912
-18
| -0.3% | -$1.44K |
|
|
SASR
490
DELISTED
Sandy Spring Bancorp Inc
SASR
| $522K | ﹤0.01% |
14,820
-5,726
| -28% | -$226K |
|
|
ABB
491
DELISTED
ABB Ltd
ABB
| $518K | ﹤0.01% |
20,200
| – | – |
|
492
General Dynamics
GD
$105B
| $516K | ﹤0.01% |
2,434
| – | – |
|
493
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
| $512K | ﹤0.01% |
4,929
-70
| -1% | -$8.19K |
|
494
Waters Corp
WAT
$36.8B
| $512K | ﹤0.01% |
1,900
| – | – |
|
495
Vanguard Large-Cap ETF
VV
$51.9B
| $507K | ﹤0.01% |
3,101
+150
| +5% | +$27.3K |
|
|
BLFY
496
DELISTED
Blue Foundry Bancorp
BLFY
| $501K | ﹤0.01% |
45,000
+5,000
| +13% | +$58.4K |
|
497
Home BancShares
HOMB
$6.21B
| $495K | ﹤0.01% |
22,000
-18,290
| -45% | -$425K |
|
498
SBA Communications
SBAC
$18.4B
| $490K | ﹤0.01% |
1,722
-35
| -2% | -$11.4K |
|
499
Brink's
BCO
$5.02B
| $487K | ﹤0.01% |
10,069
| – | – |
|
500
Amerant Bancorp
AMTB
$1.12B
| $484K | ﹤0.01% |
19,500
| – | – |
|
Similar funds
SAM
First Manhattan's Q3 2022 Portfolio in Review
As of Q3 2022, First Manhattan held 1,742 positions worth $23.6B, down 4.8% from $24.8B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
First Manhattan's Q3 2022 filing shows 84 new, 209 increased, 452 reduced and 104 closed positions. Its largest new stake was Element Solutions: 151,800 shares worth $2.47M. The largest sale was Apple, an estimated $59.9M.
By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2022 buy was Element Solutions: 151,800 shares worth $2.47M.
- First Manhattan added most to Linde in Q3 2022, an estimated $117M increase.
- First Manhattan's biggest Q3 2022 reduction was Apple, cutting an estimated $59.9M.
- First Manhattan fully exited Blueprint Medicines in Q3 2022, selling an estimated $29.7M.
- First Manhattan's ten largest holdings make up 60% of its $23.6B portfolio in Q3 2022.
- First Manhattan opened 84 new positions and closed 104 in Q3 2022.
- First Manhattan's portfolio value fell 4.8% quarter-over-quarter to $23.6B.
Based on First Manhattan's 13F filing for Q3 2022, filed 14 Nov 2022.